Perfusion Market Size is Expected to Reach USD 1527 million by 2027 at 5.4% CAGR.

Global Perfusion Market Size - Overview

The global Perfusion Market Size has been evaluated as asteadily growing market and it is expected to continue growing in future aswell. Increasing incidence of chronic diseases and related organ transplants are major drivers for this market’s growth. Moreover, technological advancements and the success rate of organ transplant has significantly increased, which is leading to the growth of this market. Increasing demand of new perfusion techniques from emerging markets of Asia, Latin America, and Eastern Europe are contributing to the growth of the global Perfusion Market Size. On the other hand, lack of donors and government regulations against paid donations are some of the factors hindering this market’s growth. According to the World Health Organization (WHO), in 2015, over 17.7 million people died from cardiovascular diseases, representing 31% of all global deaths.

Due to rising prevalence of cardiovascular diseases have gained a hugeattention of people across the globe. Moreover due to increasing number ofdeath from cardiovascular diseases, number of companies are in a race to introduce better devices and accessories for the treatment. Diabetes & obesity are the major causes for cardiovascular diseases. Increasing number of patients suffering from these diseases lead to increase in the prevalence of cardiovascular diseases, ultimately increasing the demand for the cardiovascular devices which will fuel the growth of the market.

According to findings from the WHO, in 2015, 82% of the total deathswere occurred in low- and middle-income countries. According to the Centres forDisease Control and Prevention (CDC), in 2015, over 630,000 Americans die from heart disease each year, which accounted for 1 in every 4 deaths. According to findings from the WHO in 2014, approximately 422 million people suffered from diabetes. Beside this, globally 39% of adults aged 18 years and over were overweight in 2016, and 13% were obese.

Request Free Sample Copy at:

https://www.marketresearchfuture.com/sample_request/888

Global Perfusion Market Size - RegionalAnalysis

Considering the global scenario of the perfusionmarket, there are four main regions namely America, Europe, Asia Pacific, andMiddle East & Africa. The Americas mainly includes North America andLatin America. North America is holding the largest market share. Increasingdemand of organ transplant, cardiothoracic surgeries and advanced healthcare facilities are driving the growth of the North America Perfusion Market Size. European region is the second important market, especially West European countries which are dominating this region. Eastern European countries are also showing significant growth in this market. This is due to the increasing expenditure on healthcare and related services along with government’s initiative for organ donations, this has led to a rapid growth in this market in the Asia Pacific region. Talking about the Perfusion Market Size scenario in Middle East & Africa, these regions are expected to have limited growth in the global market of perfusion. Middle East accounts for the largest market share while Africa region is growing steadily.

Global Perfusion Market Size - CompetitiveAnalysis

Getinge AB (Sweden), Medtronic (Ireland), LivaNovaPLC (U.K.), Terumo Medical Corporation (Japan), XENIOS AG (Germany), LifelineScientific, Inc. (U.S.), XVIVO Perfusion (Sweden), Repligen Corporation (U.S.), Spectrum Laboratories, Inc. (U.S.), Abbott (U.S.) Merck KGaA (Germany), Harvard Bioscience, Inc. (U.S.), Ala Science (U.S.) are some of the prominent players at the forefront of competition in the Global Perfusion Market Size and are profiled in MRFR Analysis.

Abbott is one of the major market leader in themarket with a share of 9.78% in 2016. The company adopted the strategy of FDAapprovals, and acquisition to solidify its position in the market. Additionally, the company has a huge product portfolio and good brand identity.

Sep-17  - Abbott Company has gotapproval for MRI compatibility on ellipse ICD.

Oct-17  Medtronic Company has got FDAapproval & U.S. launch of next generation pacemakers (Azure)

Oct-17  - Medtronic and Mercy announcesharing partnership to accelerate medical device innovation

Aug-17  - Abbott USFDA hadapproved the first insertable cardiac monitor the world's first smartphonecompatible ICM designed to help physicians remotely identify cardiac arrhythmias

Aug-17   - Abbott Company entered into anagreement with Roxwood Medical for product distribution in the U.S.

Jan-17   - Abbott Company acquired St.Jude Medical to strengthen its medical device leadership with innovations incardiovascular and neuromodulation segments

Jan-17  - General ElectricCompany had acquired Rapidscan Pharma Solutions Inc

Browse Detailed TOC with COVID-19 Impact Analysis at:

https://www.marketresearchfuture.com/reports/perfusion-market-888 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexityof various industries through our Cooked Research Report (CRR), Half-CookedResearch Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media PrivateLimited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com